Glen­mark gets USFDA nod for acne gel

The Financial Express - - COMPANIES -

Glen­mark Phar­ma­ceu­ti­cals has re­ceived ten­ta­tive ap­proval from the US health reg­u­la­tor USFDA for the generic ver­sion of Gal­derma Lab­o­ra­to­ries LP's Epiduo gel used in the treat­ment of acne. “Glen­mark Phar­ma­ceu­ti­cals, USA, has been granted ten­ta­tive ap­proval by the US Food and Drug Ad­min­is­tra­tion (USFDA) for ada­pa­lene and ben­zoyl per­ox­ide gel, 0.1 per cent/ 2.5%,” it said in a BSE fil­ing to­day. Ada­pa­lene and ben­zoyl per­ox­ide gel is generic ver­sion of Gal­derma Lab­o­ra­to­ries LP's Epiduo.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.